Revista de Neurología y Neurociencia

  • ISSN: 2171-6625
  • Índice h de la revista: 17
  • Puntuación de cita de revista: 4.43
  • Factor de impacto de la revista: 3.38
Indexado en
  • Abrir puerta J
  • Genamics JournalSeek
  • El Factor de Impacto Global (GIF)
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • Directorio de indexación de revistas de investigación (DRJI)
  • OCLC-WorldCat
  • Convocatoria de búsqueda
  • Factor de impacto de revista científica (SJIF)
  • pub europeo
  • Google Académico
  • Laboratorios secretos de motores de búsqueda
Comparte esta página

Abstracto

Hypothesis on the Presence of Smooth Muscle Lysis Factor as a Marker In theDiagnosis of Neuroleptic Malignant Syndrome

Hoghoughi Nazanin1*, Maroufi Azad2, Hoghoughi Negin3

Dopamine as a neurotransmitter acts to convey messages from one cell to another and it’s secretion decrease leads to numerous diseases of motor impairment such as Parkinson disease. In the same way, the use of particular drugs that block the dopamine receptors in the brain cells results in muscle rigidity increase. One of the side effects of these drugs can be Neuroleptic Malignant Syndrome (NMS). NMS is a relatively rare but potentially fatal complication of the use of neuroleptic drugs. Measuring blood CPK (Creatine Phosphokinase ) enzyme – the result of the tension and lysis in the body of stripped muscles– can be used as one of the experimental and documentary factors to diagnose and also confirm this disease.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado